Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleCrunchbase News

US Startup Funding Slows Sharply In March

View original at news.crunchbase.com
Crunchbase News - Funding Ma Title: US Startup Funding Slows Sharply In March Date: 2026-03-23 17:36 Source: https://news.crunchbase.com/business/us-startup-funding-slows-march-2026-data/ <p><span style="font-weight: 400;">After a rollicking start in </span><a href="https://news.crunchbase.com/ai/global-vc-investment-s…
Opening lines of the source · Crunchbase News · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • This month's funding deceleration is mostly a U.S. phenomenon

    60% confidence
  • A $110 billion funding round will likely take years, not weeks or months, to be topped

    60% confidence
  • The slowdown is almost entirely due to fewer giant AI megarounds closing this month

    60% confidence
  • American companies raised just around $13 billion in seed through growth-stage funding in March 2026 so far

    60% confidence
  • US startup funding slowed dramatically in March 2026 after strong January and February

    60% confidence
  • European startup funding hit its highest point of the year in March 2026

    60% confidence
  • February's U.S. funding tally will remain one for the record books

    60% confidence
  • Early- and seed-stage dealmaking in March is on track to come in close to the prior two months' levels

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com